172 related articles for article (PubMed ID: 9663184)
1. Serum sickness-like reaction to cefaclor: lack of in vitro cross-reactivity with loracarbef.
Kearns GL; Wheeler JG; Rieder MJ; Reid J
Clin Pharmacol Ther; 1998 Jun; 63(6):686-93. PubMed ID: 9663184
[TBL] [Abstract][Full Text] [Related]
2. Serum sickness-like reactions to cefaclor: role of hepatic metabolism and individual susceptibility.
Kearns GL; Wheeler JG; Childress SH; Letzig LG
J Pediatr; 1994 Nov; 125(5 Pt 1):805-11. PubMed ID: 7965438
[TBL] [Abstract][Full Text] [Related]
3. Selection of treatment of cefaclor-associated urticarial, serum sickness-like reactions and erythema multiforme by emergency pediatricians: lack of a uniform standard of care.
Joubert GI; Hadad K; Matsui D; Gloor J; Rieder MJ
Can J Clin Pharmacol; 1999; 6(4):197-201. PubMed ID: 10601753
[TBL] [Abstract][Full Text] [Related]
4. Diagnosing hypersensitivity reactions to cephalosporins in children.
Romano A; Gaeta F; Valluzzi RL; Alonzi C; Viola M; Bousquet PJ
Pediatrics; 2008 Sep; 122(3):521-7. PubMed ID: 18762521
[TBL] [Abstract][Full Text] [Related]
5. Serum sickness like illness and antimicrobials in children.
Martin J; Abbott G
N Z Med J; 1995 Apr; 108(997):123-4. PubMed ID: 7739819
[TBL] [Abstract][Full Text] [Related]
6. Loracarbef versus cefaclor in the treatment of cystitis and asymptomatic bacteriuria.
Iravani A
Clin Ther; 1992; 14(1):54-63. PubMed ID: 1576626
[TBL] [Abstract][Full Text] [Related]
7. Cefaclor-associated serum sickness-like reaction.
CMAJ; 1996 Oct; 155(7):913-20. PubMed ID: 8837539
[No Abstract] [Full Text] [Related]
8. Immediate allergic reactions to cephalosporins and penicillins and their cross-reactivity in children.
Atanasković-Marković M; Velicković TC; Gavrović-Jankulović M; Vucković O; Nestorović B
Pediatr Allergy Immunol; 2005 Jun; 16(4):341-7. PubMed ID: 15943598
[TBL] [Abstract][Full Text] [Related]
9. [Cefaclor therapy followed by serum sickness-like symptoms].
Szalai Z; Asbóth D; Török E
Orv Hetil; 1997 Apr; 138(14):855-8. PubMed ID: 9162894
[TBL] [Abstract][Full Text] [Related]
10. Cefaclor serum sickness-like reactions: report of a case and review of the literature.
Callahan CW; Musci MN; Santucci TF
J Am Osteopath Assoc; 1985 Jul; 85(7):450-2. PubMed ID: 4044329
[No Abstract] [Full Text] [Related]
11. Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature.
Knowles SR; Shapiro L; Shear NH
Arch Dermatol; 1996 Aug; 132(8):934-9. PubMed ID: 8712844
[TBL] [Abstract][Full Text] [Related]
12. Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins.
Antunez C; Blanca-Lopez N; Torres MJ; Mayorga C; Perez-Inestrosa E; Montañez MI; Fernandez T; Blanca M
J Allergy Clin Immunol; 2006 Feb; 117(2):404-10. PubMed ID: 16461141
[TBL] [Abstract][Full Text] [Related]
13. Anaphylactic reaction to oral cefaclor in a child.
Grouhi M; Hummel D; Roifman CM
Pediatrics; 1999 Apr; 103(4):e50. PubMed ID: 10103342
[TBL] [Abstract][Full Text] [Related]
14. Multiple antibiotic sensitivity syndrome in children.
Park J; Matsui D; Rieder MJ
Can J Clin Pharmacol; 2000; 7(1):38-41. PubMed ID: 10822212
[TBL] [Abstract][Full Text] [Related]
15. New warning about cefaclor and serum sickness in children.
Phillips R
Aust Fam Physician; 1999 Jun; 28(6):539. PubMed ID: 10399381
[No Abstract] [Full Text] [Related]
16. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
Schmid DA; Depta JP; Pichler WJ
Clin Exp Allergy; 2006 Jan; 36(1):59-69. PubMed ID: 16393267
[TBL] [Abstract][Full Text] [Related]
17. Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis.
Hyslop DL; Bischoff W
Am J Med; 1992 Jun; 92(6A):86S-94S. PubMed ID: 1621752
[TBL] [Abstract][Full Text] [Related]
18. Cefaclor serum sickness.
Grammer LC
JAMA; 1996 Apr; 275(15):1152-3. PubMed ID: 8609672
[No Abstract] [Full Text] [Related]
19. Serum sickness in a paediatric emergency department: the role of cefaclor.
Parshuram CS; Phillips RJ; Nash MC
J Paediatr Child Health; 1999 Apr; 35(2):223-4. PubMed ID: 10365368
[No Abstract] [Full Text] [Related]
20. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
McCarty J; Ruoff GE; Jacobson KD
Am J Med; 1992 Jun; 92(6A):80S-85S. PubMed ID: 1621751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
